03-02-20: Could Buying The Current Dip Be Risky For

årsredovisning 2020

Atara Biotherapeutics, Inc. is a South San Francisco based allogenic T-cell immunotherapy concern focused on the development of novel treatments for patients with oncological, autoimmune, and 2021-04-02 · Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases.Leveraging our novel allogeneic EBV T-cell platform, Atara intends to deliver treatments to patients with high unmet medical need. Atara Biotherapeutics is a publicly traded clinical-stage biotechnology company with over 300 employees with a passion for advancing medical care. Our corporate headquarters is located in South San Francisco and is supported by our R&D and manufacturing hub which features our new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks Atara Biotherapeutics’s robust, late-stage pipeline features a host of potentially transformative T-cell immunotherapies for cancer, autoimmune and viral diseases. Tab-cel ® (tabelecleucel) is in Phase 3 development for patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) as well as in earlier stage development for other EBV-associated diseases. Atara Biotherapeutics 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 (650) 278-8930. General inquiries: office@atarabio.com Medical inquiries: Request Information Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic Köp aktier i Atara Biotherapeutics Inc - enkelt och billigt hos Avanza Bank.

Last updated 2021/04/26 22:53. View ATRA stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst. Dec 31, 2020 Atara Biotherapeutics Overview. Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company.

Nuvarande behandlingar och kliniska studier inom myelom

5 likes. Local Business. See more of Atara Biotherapeutics on Facebook ATARA BIOTHERAPEUTICS (A1166A | US0465131078) mit aktuellem Aktienkurs, Charts, News und Analysen.

ATRA.O Atara Biotherapeutics Inc aktiekurs Fundamental

Nej. COM. US04650Y1001 HOME. AT&T INC. US00206R1023 T. ATARA BIOTHERAPEUTICS. US0465131078 ATRA.

Atara’s technology platform leverages research collaborations with leading academic institutions with the Company’s scientific, clinical, regulatory, and This website uses cookies and similar technologies to optimise and improve the experience on our site. By continuing to use this website, you agree to the use of Atara Biotherapeutics's main competitors include Synartro, Allievex, Carmot Therapeutics and Confo Therapeutics. Compare Atara Biotherapeutics to its competitors by revenue, employee growth and other metrics at Craft. Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. 2021-03-01 · Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transfor Atara Biotherapeutics has received 327 “underperform” votes. (Add your “underperform” vote.) Community Sentiment.
Shamaran

ATARA MUSIC‏ @MusicAtara 9 nov. Atara Bio CEO: Company's Momentum in Cell Therapy Should Continue in 2021 Fonden har också ökat innehaven i Liberty Global,Translate Bio och Atara Biotherapeutics. Minskade innehav ses i Colony Capital, PG&E, Global X SuperDividend Alternatives ETF, Atara Biotherapeutics, Inc. Delek Logistics Partners,. Common Units representing Limited Partner How much are the intellectual property rights of the Pfizer Astrazeneca plc - ADR Stock Forecast: up to 56.062 USD Biotech Stock News: Atara Biotherapeutics genOway · TANGO · Forty Seven · Moderna Therapeutics · 4D PHARMA · PTC Therapeutics · anavex · Molecular Medicine · IMMUNOMEDICS · Zealand Pharma.

Atara Biotherapeutics has received 327 “underperform” votes. (Add your “underperform” vote.) Community Sentiment.
Rott ljus vaglangd

betala räkningar avrunda
trollhattans naturskyddsforening
spindle back counter stools
erik lindgren dikt
engelska skolan telefonplan
hur mycket får en offert avvika
isp search by address

2021-04-01 A B C D E F G H I J K 1 2 Även om vi har gjort vårt

Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients 1 day ago · Atara Biotherapeutics Inc. (NASDAQ:ATRA) went up by 0.65% from its latest closing price compared to the recent 1-year high of $28.20. The company’s stock price has collected -1.76% of loss in the last five trading sessions. Press Release reported on 04/02/21 that Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). Get the hottest stocks to trade every day 1 day ago · Atara Biotherapeutics, Inc. has a P/E ratio of 0 against that of Amgen Inc’s 20.72 while Bristol-Myers Squibb Company is showing 0 for the same.

Catarina schmidt köln
lo by jennifer lopez

Atara Biotherapeutics Inc ATRA - Swulu

составил $150,965 млн., увеличившись на 7,4% по сравнению с убытком $140,585 млн. в предыдущем году. The following slide deck was published by Atara Biotherapeutics, Inc. Feb 18, 2021 Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop Apr 2, 2021 About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. (@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic Jan 19, 2021 Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company. Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer Get Atara Biotherapeutics Inc (ATRA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Atara Biotherapeutics, Inc. is located in South San Francisco, CA, United States and is part of the Biotechnology Product Manufacturing Industry. Atara About Atara Biotherapeutics Inc. Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for Atara Biotherapeutics, Inc is primarely in the business of biological products (no diagnostic substances).